$13.65
-0.37-2.64%
al cierre: Nov 16, 4:00 PM EST
$13.65
N/A
After hour: 4:00 PM EST
BlossomHill Therapeutics (BLSM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-1.29 | $-0.90 | -43.3 % |
| Q2 | Sep 18, 2026 | $-8.75 | $-0.77 | -1036.4 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Estimate | $-0.90 | $-0.77 |
| Actual | $-1.29 | $-8.75 |
| Surprise | -43.3% | -1036.4% |
| Revenue | ||
| Estimate | — | — |
| Actual | $0 | $0 |
| Surprise | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-1.01 | $-0.86 | $-0.77 |
| Revenue | |||
| Consensus | — | — | — |
